Position in GMED
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$31,598,627
-$35,074,910 QoQ
Shares Held
399,932
-48.3% QoQ
Ownership
0.298%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#60
of 598 holders
Holding Since
Dec 2020
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GMED Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Holocene Advisors, LP holds $1,102,327,393 across 15 Medical Devices names. GMED ranks #9 (2.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EW |
Edwards Lifesciences Corp
|
3,139,285 | $283,979,721 | |
| 2 | ABT |
Abbott Laboratories
|
2,490,670 | $226,003,395 | |
| 3 | GKOS |
GLAUKOS Corp
|
1,514,931 | $211,726,756 | |
| 4 | ZBH |
Zimmer Biomet Holdings, Inc.
|
1,177,461 | $101,367,617 | |
| 5 | IRTC |
iRhythm Holdings, Inc.
|
783,636 | $93,213,502 | |
| 6 | HAE |
Haemonetics Corp
|
550,195 | $41,264,625 | |
| 7 | PEN |
Penumbra Inc
|
128,012 | $40,419,789 | |
| 8 | BSX |
Boston Scientific Corp
|
806,732 | $34,431,321 |
All Filings in GMED
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $31,598,627 | 399,932 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $66,673,537 | 773,834 | Shares | Sole | 2026-05-15 | |
| 2025-03-31 | $33,678,368 | 460,087 | Shares | Sole | 2025-05-15 | |
| 2023-12-31 | $7,311,014 | 137,193 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $4,148,555 | 83,556 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $7,826,949 | 131,457 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $898,706 | 15,867 | Shares | Sole | 2023-05-15 | |
| 2021-03-31 | $659,313 | 10,691 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $505,194 | 7,746 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||